About Biohit Oyj

Company Description

Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit's mission is "Innovating for Health"​. We are committed to social responsibility and it is our duty to spread knowledge about the Group I human carcinogen, acetaldehyde, and innovate and develop the marketing and availability of our products and services. Biohit is headquartered in Helsinki, Finland and its subsidiaries are located in China, Italy and the United Kingdom.

Product range consists of products and analysis systems for the early diagnosis of gastrointestinal diseases, such as the blood-sample based GastroPanel examinations for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of fecal occult intestinal bleeding (faecal occult blood) that indicates a risk of colorectal cancer.

Year founded

1988

Served area

Worldwide

Headquarters

Laippatie 1, 880 Helsinki – Finland

Shareholder information

Shares outstanding

15,045,593

IPO

Jan. 1, 2000

Stock exchange(s)

Nasdaq Helsinki

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.